Diaz Luis 4
4 · Jounce Therapeutics, Inc. · Filed Jun 28, 2022
Insider Transaction Report
Form 4
Diaz Luis
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-24+20,000→ 20,000 totalExercise: $2.80Exp: 2032-06-24→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option will vest in equal quarterly installments during the four quarters following the grant date, provided that if the Issuer's 2023 annual meeting of stockholders occurs before the one-year anniversary of the grant date, the unvested portion of the option will vest as of the date of such annual meeting, subject in each case to the Reporting Person's continued service on the Issuer's board of directors.